GVG COPRPORATE FINANCE ADVISORS ADVISES THE SHAREHOLDERS OF NEC MED PHARMA GMBH ON THE SALE OF THE MAJORITY OF THE SHARES TO NORD HOLDING

NORD Holding Unternehmensbeteiligungsgesellschaft mbH acquires a majority stake in NEC MED PHARMA GmbH, based in Höchstadt an der Aisch. (www.nec-med-pharma.de)
 
NEC MED PHARMA is a specialized distributor of pharmaceutical and medical devices in Germany. The company has a broad, cross-trade supplier base and is a sales partner for a large number of established manufacturers. NEC MED generated sales of € 90 million in 2016 and employs around 50 people. With an average growth rate of over 10%, the business has grown continuously in recent years.
The investment of NORD Holding is intended to further expand its leading market position.
Sven Rübner, Managing Partner of NEC MED PHARMA: "My co-shareholders and I would like to thank GVG for its commitment and support in the search for a new majority shareholder. With NORD Holding, I have been able to gain an experienced partner who can optimally support me in continuing my growth course."

Volker Werner, Partner at GVG Corporate Finance Advisors, comments: "We are pleased to have been able to support the existing shareholders of NEC MED PHARMA in the structured sales process. We are sure that with Nord Holding we have found the perfect partner for the further expansion and internationalization of NEC MED PHARMA."